Home » News » Awards & Advancement » Trophos appoints Christine Placet as CEO

Trophos appoints Christine Placet as CEO

Monday, June 18, 2012

Trophos, a French clinical stage pharmaceutical company developing therapeutics for under-served needs in neurology and cardiology, has appointed Christine Placet as chief executive officer.

Placet has served as CFO of Trophos since 2004 and has over 25 years of experience. She becomes CEO under a previously defined internal succession plan designed to provide continuity for Trophos. Prior to joining Trophos, Placet served as CFO in a number of growing companies and start-ups in various industries, and worked as an auditor for eight years for Ernst & Young.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!